Latest News for: life science

Edit

Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $17.6 Million (Form 6-K) (Tiziana Life Sciences Ltd)

Public Technologies 16 Jan 2026
Your belief in Tiziana Life Sciences has been instrumental as we push forward to topline data in our clinical trials in na-SPMS and MSA, bringing us closer to potential breakthroughs that could ...
Edit

Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares

Nasdaq Globe Newswire 16 Jan 2026
BOSTON, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq ... The gross proceeds to Tiziana from the Offering, before deducting estimated Offering expenses payable by Tiziana, were $8.8 million ... .
Edit

Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $17.6 Million

Nasdaq Globe Newswire 16 Jan 2026
BOSTON, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq ... The total gross proceeds to Tiziana from the Offering, before deducting estimated Offering expenses payable by Tiziana, are expected to be $8.0 million ... .
Edit

Orrick Advises Tiziana Life Sciences on Nasdaq Registered Direct Offering of Up to Approximately $17.6 Million (Orrick, Herrington & Sutcliffe LLP)

Public Technologies 16 Jan 2026
). Orrick represented Tiziana Life Sciences Ltd. (Nasdaq. TLSA) ("Tiziana") on its registered direct offering of 6.4 million new ordinary shares at $1.25 each, for gross proceeds of approximately $8 million ... THE COMPANY ... THE IMPACT ... THE TEAM.
Edit

LIR Life Sciences Launches Comparative Animal Study to Advance Transdermal Delivery of Second Generation GLP/GIP-based ...

ACCESSWIRE 16 Jan 2026
VANCOUVER, BC / ACCESS Newswire / January 15, 2026 / LIR Life Sciences Corp ... AboutLIR Life Sciences Corp. LIR Life Sciences is focused on researching and developing scalable and affordable treatments for obesity using novel drug delivery methods.
Edit

Amendment to Notice of Sales of Unregistered Securities (Form D/A) (Driehaus Life Sciences Fund Ltd)

Public Technologies 16 Jan 2026
) ... The reader should not assume that the information is accurate and complete ... Washington, D.C. 20549. FORM D ... OMB APPROVAL ... Driehaus Life Sciences Fund, Ltd ... Driehaus Life Sciences Fund, Ltd ... Driehaus Life Sciences Fund, Ltd ... Driehaus Life Sciences Fund Ltd.
Edit

Supplemental Prospectus (Form 424B5) (Tiziana Life Sciences Ltd)

Public Technologies 16 Jan 2026
... succession to us, and the holders of ordinary shares of Tiziana Life Sciences plc received new common shares of the Bermuda company in exchange for their ordinary shares of Tiziana Life Sciences plc.
Edit

Izertis leads Adamed’s digital transformation with Salesforce Agentforce Life Sciences (Izertis SA)

Public Technologies 15 Jan 2026
... of prescription drugs, will modernise its commercial operations and deepen customer relationships with Salesforce's Agentforce Life Sciences for Customer Engagement.
Edit

Letter to global governments: A call for bold life sciences investment (Novartis AG)

Public Technologies 15 Jan 2026
Life sciences innovation in advanced economies is under threat-not from a lack of talent, ideas, or scientific leadership, but from policy failures ... The Covid-19 pandemic proved that life sciences ...
Edit

Adamed Selects Salesforce Agentforce Life Sciences for Customer Engagement to Power Commercial Growth in Spain (Salesforce Inc)

Public Technologies 15 Jan 2026
"The selection of Agentforce Life Sciences for Customer Engagement by Adamed is a powerful validation of our unified platform strategy," said Frank Defesche, SVP and GM at Agentforce Life Sciences.
×